336 related articles for article (PubMed ID: 33278109)
21. Intracranial ependymomas: molecular insights and translation to treatment.
Lester A; McDonald KL
Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
[TBL] [Abstract][Full Text] [Related]
22. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
Dorfer C; Tonn J; Rutka JT
Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
[TBL] [Abstract][Full Text] [Related]
23. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.
Ellison DW; Aldape KD; Capper D; Fouladi M; Gilbert MR; Gilbertson RJ; Hawkins C; Merchant TE; Pajtler K; Venneti S; Louis DN
Brain Pathol; 2020 Sep; 30(5):863-866. PubMed ID: 32502305
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in the Classification and Treatment of Ependymomas.
Leeper H; Felicella MM; Walbert T
Curr Treat Options Oncol; 2017 Aug; 18(9):55. PubMed ID: 28795287
[TBL] [Abstract][Full Text] [Related]
25. Genetic expression profiles of adult and pediatric ependymomas: molecular pathways, prognostic indicators, and therapeutic targets.
Nagasawa DT; Trang A; Choy W; Spasic M; Yew A; Zarinkhou G; Garcia HM; Yang I
Clin Neurol Neurosurg; 2013 Apr; 115(4):388-99. PubMed ID: 23374238
[TBL] [Abstract][Full Text] [Related]
26. H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.
Kleinschmidt-DeMasters BK; Mulcahy Levy JM
Clin Neuropathol; 2018; 37 (2018)(2):53-63. PubMed ID: 29393845
[TBL] [Abstract][Full Text] [Related]
27. Advances and controversies in the management of childhood brain tumors.
Kuttesch JF
Curr Opin Oncol; 1997 May; 9(3):235-40. PubMed ID: 9229145
[TBL] [Abstract][Full Text] [Related]
28. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
29. Classification and Grading of Central Nervous System Tumors According to the World Health Organization 5th Edition.
Yoda RA; Cimino PJ
Semin Neurol; 2023 Dec; 43(6):833-844. PubMed ID: 37949117
[TBL] [Abstract][Full Text] [Related]
30. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
31. Pediatric Glial Tumors.
Viaene AN; Santi M; Hawkins C
Pediatr Dev Pathol; 2022; 25(1):46-58. PubMed ID: 33872106
[TBL] [Abstract][Full Text] [Related]
32. Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas.
Bayliss J; Mukherjee P; Lu C; Jain SU; Chung C; Martinez D; Sabari B; Margol AS; Panwalkar P; Parolia A; Pekmezci M; McEachin RC; Cieslik M; Tamrazi B; Garcia BA; La Rocca G; Santi M; Lewis PW; Hawkins C; Melnick A; David Allis C; Thompson CB; Chinnaiyan AM; Judkins AR; Venneti S
Sci Transl Med; 2016 Nov; 8(366):366ra161. PubMed ID: 27881822
[TBL] [Abstract][Full Text] [Related]
33. Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas.
Schreck KC; Ranjan S; Skorupan N; Bettegowda C; Eberhart CG; Ames HM; Holdhoff M
J Neurooncol; 2019 May; 143(1):87-93. PubMed ID: 30864101
[TBL] [Abstract][Full Text] [Related]
34. Pediatric gliomas.
Pfister S; Witt O
Recent Results Cancer Res; 2009; 171():67-81. PubMed ID: 19322538
[TBL] [Abstract][Full Text] [Related]
35. Shared molecular targets in pediatric gliomas and ependymomas.
Tsuruta T; Aihara Y; Kanno H; Funase M; Murayama T; Osawa M; Fujii H; Kubo O; Okada Y
Pediatr Blood Cancer; 2011 Dec; 57(7):1117-23. PubMed ID: 21298772
[TBL] [Abstract][Full Text] [Related]
36. Brain tumors in children--current therapies and newer directions.
Khatua S; Sadighi ZS; Pearlman ML; Bochare S; Vats TS
Indian J Pediatr; 2012 Jul; 79(7):922-7. PubMed ID: 22294272
[TBL] [Abstract][Full Text] [Related]
37. Pediatric low-grade gliomas: implications of the biologic era.
Packer RJ; Pfister S; Bouffet E; Avery R; Bandopadhayay P; Bornhorst M; Bowers DC; Ellison D; Fangusaro J; Foreman N; Fouladi M; Gajjar A; Haas-Kogan D; Hawkins C; Ho CY; Hwang E; Jabado N; Kilburn LB; Lassaletta A; Ligon KL; Massimino M; Meeteren SV; Mueller S; Nicolaides T; Perilongo G; Tabori U; Vezina G; Warren K; Witt O; Zhu Y; Jones DT; Kieran M
Neuro Oncol; 2017 Jun; 19(6):750-761. PubMed ID: 27683733
[TBL] [Abstract][Full Text] [Related]
38. H3 K27M mutations are extremely rare in posterior fossa group A ependymoma.
Ryall S; Guzman M; Elbabaa SK; Luu B; Mack SC; Zapotocky M; Taylor MD; Hawkins C; Ramaswamy V
Childs Nerv Syst; 2017 Jul; 33(7):1047-1051. PubMed ID: 28623522
[TBL] [Abstract][Full Text] [Related]
39. Ependymoma.
Gerstner ER; Pajtler KW
Semin Neurol; 2018 Feb; 38(1):104-111. PubMed ID: 29548057
[TBL] [Abstract][Full Text] [Related]
40. [Classification and Diagnostics of Pediatric Brain Tumors].
Kanemura Y
No Shinkei Geka; 2023 Sep; 51(5):778-788. PubMed ID: 37743329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
